Kun Zhou

1.1k total citations
27 papers, 666 citations indexed

About

Kun Zhou is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Kun Zhou has authored 27 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 8 papers in Cancer Research and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Kun Zhou's work include Epigenetics and DNA Methylation (8 papers), MicroRNA in disease regulation (4 papers) and Cancer-related molecular mechanisms research (4 papers). Kun Zhou is often cited by papers focused on Epigenetics and DNA Methylation (8 papers), MicroRNA in disease regulation (4 papers) and Cancer-related molecular mechanisms research (4 papers). Kun Zhou collaborates with scholars based in China, United States and Saudi Arabia. Kun Zhou's co-authors include Jinjun Shi, Bruce R. Zetter, Mikyung Yu, Gha Young Lee, Wuji Cao, Morteza Mahmoudi, Harshal Zope, Philip W. Kantoff, Omid C. Farokhzad and Yingjie Xu and has published in prestigious journals such as Nano Letters, PLoS ONE and The Science of The Total Environment.

In The Last Decade

Kun Zhou

27 papers receiving 664 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kun Zhou China 13 459 159 86 81 74 27 666
Chien‐Yu Lin Taiwan 15 466 1.0× 235 1.5× 51 0.6× 59 0.7× 78 1.1× 44 869
Chengyan Wang China 14 533 1.2× 103 0.6× 81 0.9× 88 1.1× 28 0.4× 41 797
Uksha Saini United States 14 363 0.8× 209 1.3× 54 0.6× 89 1.1× 53 0.7× 26 584
Guanghui Cui China 18 431 0.9× 216 1.4× 25 0.3× 58 0.7× 40 0.5× 51 783
Anna Fiszer-Kierzkowska Poland 10 294 0.6× 111 0.7× 28 0.3× 44 0.5× 50 0.7× 17 520
Quan Zhou China 17 487 1.1× 325 2.0× 88 1.0× 78 1.0× 23 0.3× 40 784
You Hee Choi South Korea 16 634 1.4× 96 0.6× 145 1.7× 84 1.0× 67 0.9× 34 857
Nirmal Rajasekaran South Korea 10 344 0.7× 126 0.8× 36 0.4× 49 0.6× 57 0.8× 20 526
Samar Abdulkhalek Canada 14 412 0.9× 84 0.5× 47 0.5× 232 2.9× 86 1.2× 17 691

Countries citing papers authored by Kun Zhou

Since Specialization
Citations

This map shows the geographic impact of Kun Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Zhou more than expected).

Fields of papers citing papers by Kun Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kun Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Zhou. The network helps show where Kun Zhou may publish in the future.

Co-authorship network of co-authors of Kun Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Kun Zhou. A scholar is included among the top collaborators of Kun Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kun Zhou. Kun Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deng, Wei, Zhaoyue Wang, Yanxia Wang, et al.. (2023). Genetics of congenital heart disease. Clinica Chimica Acta. 552. 117683–117683. 3 indexed citations
2.
Zhou, Zhi‐Xiang, Wenhao Xiong, Miao Jiang, et al.. (2023). TRIM65 promotes vascular smooth muscle cell phenotypic transformation by activating PI3K/Akt/mTOR signaling during atherogenesis. Atherosclerosis. 390. 117430–117430. 8 indexed citations
3.
Wang, Yanxia, et al.. (2023). Biological functions of CRTC2 and its role in metabolism-related diseases. Journal of Cell Communication and Signaling. 17(3). 495–506. 5 indexed citations
4.
Zhou, Kun, Jae Eun Cheong, Aram Ghalali, et al.. (2022). Inhibition of Wnt Signaling in Colon Cancer Cells via an Oral Drug that Facilitates TNIK Degradation. Molecular Cancer Therapeutics. 22(1). 25–36. 18 indexed citations
5.
Zhou, Kun, et al.. (2022). Hippo: A New Hub for Atherosclerotic Disease. Current Pharmaceutical Design. 28(16). 1321–1328. 2 indexed citations
6.
Xu, Qiaoqiao, Mingming Yu, Yüxia Zhou, et al.. (2021). Effects of 2,2′,4,4′-tetrabromodiphenyl ether on the development of mouse embryonic stem cells. Reproductive Toxicology. 106. 18–24. 3 indexed citations
7.
Wang, Yu, Li Zhu, Mei Guo, et al.. (2021). Histone methyltransferase WHSC1 inhibits colorectal cancer cell apoptosis via targeting anti-apoptotic BCL2. Cell Death Discovery. 7(1). 19–19. 18 indexed citations
8.
Tian, Zhen, Wen Luo, Kun Zhou, et al.. (2021). Sestrin2 in atherosclerosis. Clinica Chimica Acta. 523. 325–329. 8 indexed citations
9.
Zhou, Kun, Wen Luo, Zhong Ren, et al.. (2021). A promising field: regulating imbalance of EndMT in cardiovascular diseases. Cell Cycle. 20(15). 1477–1486. 9 indexed citations
10.
Zhang, Heng, Ting Lu, Xian Sun, et al.. (2019). A metabolomic study on the gender-dependent effects of maternal exposure to fenvalerate on neurodevelopment in offspring mice. The Science of The Total Environment. 707. 136130–136130. 18 indexed citations
11.
Islam, Mohammad Ariful, Yingjie Xu, Wei Tao, et al.. (2018). Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA. Nature Biomedical Engineering. 2(11). 850–864. 263 indexed citations
12.
Zhou, Kun, et al.. (2017). MicroRNA-30a suppresses tumor progression by blocking Ras/Raf/MEK/ERK signaling pathway in hepatocellular carcinoma. Biomedicine & Pharmacotherapy. 93. 1025–1032. 29 indexed citations
13.
Liu, Zhiqin, et al.. (2016). Effect of metformin on global gene expression in liver of KKAy mice. Pharmacological Reports. 68(6). 1332–1338. 9 indexed citations
14.
Zhou, Zhigang, Liping Wan, Chun Wang, & Kun Zhou. (2015). Integration of Shh and Wnt Signaling Pathways Regulating Hematopoiesis. DNA and Cell Biology. 34(12). 710–716. 4 indexed citations
15.
Chen, Minjian, Meiping Shen, Yanyun Li, et al.. (2015). GC-MS-based metabolomic analysis of human papillary thyroid carcinoma tissue. International Journal of Molecular Medicine. 36(6). 1607–1614. 49 indexed citations
16.
Zhou, Zhigang, Liping Wan, Yin Tong, et al.. (2015). Targeting the Sonic Hedgehog-Gli1 Pathway as a Potential New Therapeutic Strategy for Myelodysplastic Syndromes. PLoS ONE. 10(8). e0136843–e0136843. 13 indexed citations
17.
Xu, Bo, Minjian Chen, Xiaoli Ji, et al.. (2015). Metabolomic profiles reveal key metabolic changes in heat stress-treated mouse Sertoli cells. Toxicology in Vitro. 29(7). 1745–1752. 38 indexed citations
18.
Liang, Hongyan, Li Xue, Chun Yang, et al.. (2012). Potential clinical significance of plasma-based KRAS mutation analysis using the COLD-PCR/TaqMan® -MGB probe genotyping method. Experimental and Therapeutic Medicine. 4(1). 109–112. 19 indexed citations
19.
Zhou, Kun, Lifang Huang, Zhigang Zhou, et al.. (2010). Wnt and Notch signaling pathways selectively regulating hematopoiesis. Annals of Hematology. 89(8). 749–757. 15 indexed citations
20.
Zhou, Kun, et al.. (2009). Fetal liver stromal cells promote hematopoietic cell expansion. Biochemical and Biophysical Research Communications. 387(3). 596–601. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026